Genotoxicity of environmental tobacco smoke: A review

Mutation Research - Reviews in Mutation Research

Volumn 567, Issue 2-3 SPEC. ISS., 2004, Pages 427-445

  Husgafvel Pursiainen, Kirsti ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Biomarkers; Environmental tobacco smoke; Genotoxicity; Involuntary smoking; Passive smoking; Second hand smoke

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; TOBACCO SMOKE;

BACTERIAL MUTATION; BIOLOGICAL MONITORING; CANCER INCIDENCE; CARCINOGENESIS; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE MARKER; DNA DEGRADATION; DNA STRAND BREAKAGE; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTOXICITY; HUMAN; LUNG CANCER; MOLECULAR MECHANICS; MUTAGENICITY; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; REVIEW; SALMONELLA; SMOKING;

AIR POLLUTION, INDOOR; CARCINOGENS; CHROMOSOME ABERRATIONS; DNA DAMAGE; FEMALE; HUMANS; LUNG NEOPLASMS; MATERNAL-FETAL EXCHANGE; MUTAGENS; MUTATION; POLYMORPHISM, GENETIC; PREGNANCY; TOBACCO SMOKE POLLUTION;

BACTERIA (MICROORGANISMS); NICOTIANA TABACUM; RODENTIA;

EID: 9644269056     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2004.06.004     Document Type: Review

References (169)

1. U.S. Environmental Protection Agency, Respiratory health effects of passive smoking: lung cancer and other disorders, The Report of the U.S. Environmental Protection Agency, NIH Publication No. 93-3605, 1993.
2. National Cancer Institute, Smoking and Tobacco Control Monograph 10, Health Effects of Exposure to Environmental Tobacco Smoke, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, 1999 (Californian Environmental Protection Agency, Office of Environmental Health Hazard Assessment, San Francisco, CA, 1997).
3. U.S. Department of Health and Human Services, Report on Carcinogens, tenth ed., U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, 2002.
4. International Agency for Research on Cancer (IARC), Tobacco smoke and involuntary smoking, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 83, International Agency for Research on Cancer, WHO, Lyon, France, 2004.
5. P. Vineis, M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y.T. Gao, P.C. Gupta, A. Hackshaw, E. Matos, J. Samet, F. Sitas, J. Smith, L. Stayner, K. Straif, M.J. Thun, H.E. Wichmann, A.H. Wu, D. Zaridze, R. Peto, and R. Doll Tobacco and cancer: recent epidemiological evidence J. Natl. Cancer Inst. 2 2004 99 106
6. International Agency for Research on Cancer (IARC) Tobacco smoking, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans vol. 38 1986 International Agency for Research on Cancer Lyon
7. National Research Council Environmental tobacco smoke: measuring exposures and assessing health effects 1986 National Academy Press Washington, DC
8. International Agency for Research on Cancer (IARC), Overall evaluations of carcinogenicity: an updating of IARC Monographs vols. 1-42, IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Suppl. 7, International Agency for Research on Cancer, Lyon, 1987.
9. D.M. DeMarini Genotoxicity of tobacco smoke and tobacco smoke condensate Mutat. Res. 114 1983 59 89
10. D.M. DeMarini Genotoxicity of tobacco smoke and tobacco smoke condensate: a review Mutat. Res. 567 2004 447 474
11. E. Bermúdez, K. Stone, K.M. Carter, and W.A. Pryor Environmental tobacco smoke is just as damaging to DNA as mainstream smoke Environ. Health Perspect. 102 1994 870 874
12. L. Wolz, G. Krause, G. Scherer, M. Aufderheide, and U. Mohr In vitro genotoxicity assay of sidestream smoke using a human bronchial epithelial cell line Food Chem. Toxicol. 40 2002 845 850
13. C.-C. Chen, and H. Lee Genotoxicity and DNA adduct formation of incense smoke condensates: comparison with environmental tobacco smoke condensates Mutat. Res. 367 1996 105 114
14. K. Husgafvel-Pursiainen, M. Sorsa, M. Moller, and C. Benestad Genotoxicity and polynuclear aromatic hydrocarbon analysis of environmental tobacco smoke samples from restaurants Mutagenesis 1 1986 287 292
15. G. Löfroth, and G. Lazaridis Environmental tobacco smoke: comparative characterization by mutagenicity assays of sidestream and mainstream cigarette smoke Environ. Mutagen. 8 1986 693 704
16. P.I. Ling, G. Löfroth, and J. Lewtas Mutagenic determination of passive smoking Toxicol. Lett. 35 1987 147 151
17. R.S. Morin, J.J. Tulis, and L.D. Claxton The effect of solvent and extraction methods on the bacterial mutagenicity of sidestream cigarette smoke Toxicol. Lett. 38 1987 279 290
18. G. Löfroth, P.I. Ling, and E. Agurell Public exposure to environmental tobacco smoke Mutat. Res. 202 1988 103 110
19. L.D. Claxton, M.S. Morin, T.J. Hughes, and J. Lewtas A genotoxic assessment of environmental tobacco smoke using bacterial assays Mutat. Res. 222 1989 81 99
20. D.J. Doolittle, C.K. Lee, J.L. Ivett, J.C. Mirsalis, E. Riccio, C.J. Rudd, G.T. Burger, and A.W. Hayes Genetic toxicology studies comparing the activity of sidestream smoke from cigarettes which burn or only heat tobacco Mutat. Res. 240 1990 59 72
21. G. Löfroth Environmental tobacco smoke: overview of chemical composition and genotoxic components Mutat. Res. 222 1989 73 80
22. J. Lewtas, L. Claxton, J. Mumford, and G. Lofroth Bioassay of complex mixtures of indoor air pollutants IARC Sci. Publ. 109 1993 85 95
23. O.T. Chortyk, and W.J. Chamberlain A study on the mutagenicity of tobacco smoke from low-tar cigarettes Arch. Environ. Health 45 1990 237 244
24. S. Azuma, S. Kishino, S. Katayama, Y. Akahori, and H. Matsushita Highly sensitive mutation assay for mutagenicity monitoring of indoor air using Salmonella typhimurium YG1041 and a microsuspension method Mutagenesis 12 1997 373 377
25. B.R. Bombick, J.T. Avalos, P.R. Nelson, F.W. Conrad, and D.J. Doolittle Comparative studies of the mutagenicity of environmental tobacco smoke from cigarettes that burn or primarily heat tobacco Environ. Mol. Mutagen. 31 1998 169 175
26. C.J. Smith, D.W. Bombick, B.A. Ryan, W.T. Morgan, and D.J. Doolittle Urinary mutagenicity in nonsmokers following exposure to fresh diluted sidestream cigarette smoke Mutat. Res. 470 2000 53 70
27. N.Y. Kado, S.A. McCurdy, S.J. Tesluk, S.K. Hammond, D.P. Hsieh, J. Jones, and M.B. Schenker Measuring personal exposure to airborne mutagens and nicotine in environmental tobacco smoke Mutat. Res. 261 1991 75 82
28. R. Zhou, S. Li, Y. Zhou, and A. Haug Comparison of environmental tobacco smoke concentrations and mutagenicity for several indoor environments Mutat. Res. 465 2000 191 200
29. S. Salomaa, J. Tuominen, and E. Skyttä Genotoxicity and PAC analysis of particulate and vapour phases of environmental tobacco smoke Mutat. Res. 204 1988 173 183
30. A.H. Trivedi, B.J. Dave, and S.G. Adhvaryu Assessment of genotoxicity of nicotine employing in vitro mammalian test system Cancer Lett. 54 1990 89 94
31. C.K. Lee, B.G. Brown, B.A. Reed, C.A. Rahn, C.R.E. Coggins, D.J. Doolittle, and A.W. Hayes Fourteen-day inhalation study in rats, using aged and diluted sidestream smoke from a reference cigarette Fundam. Appl. Toxicol. 19 1992 141 146
32. C.K. Lee, B.G. Brown, B.A. Reed, C.A. Rahn, C.R.E. Coggins, D.J. Doolittle, and A.W. Hayes Ninety-day inhalation study in rats, using aged and diluted sidestream smoke from a reference cigarette: DNA adducts and alveolar macrophage cytogenetics Fundam. Appl. Toxicol. 20 1993 393 401
33. J. Takenawa, Y. Kaneko, K. Okumura, H. Nakayama, J. Fujita, and O. Yoshida Urinary excretion of mutagens and covalent DNA damage induced in the bladder and kidney after passive smoking in rats Urol. Res. 22 1994 93 97
34. A. Izzotti, R.M. Balansky, N. Coscia, L. Scatolini, F. D'Agostini, and S. De Flora Chemoprevention of smoke-related DNA adduct formation in rat lung and heart Carcinogenesis 13 1992 2187 2190
35. A. Izzotti, M. Bagnasco, F. D'Agostini, C. Cartiglia, R.A. Lubet, G.J. Kelloff, and S. De Flora Formation and persistence of nucleotide alterations in rats exposed whole-body to environmental cigarette smoke Carcinogenesis 20 1999 1499 1505
36. A. Izzotti, R.M. Balansky, F. Dagostini, C. Bennicelli, S.R. Myers, C.J. Grubbs, R.A. Lubet, G.J. Kelloff, and S. De Flora Modulation of biomarkers by chemopreventive agents in smoke-exposed rats Cancer Res. 61 2001 2472 2479
37. R.M. Balansky, A. Izzotti, F. D'Agostini, A. Camoirano, M. Bagnasco, R.A. Lubet, and S. De Flora Systemic genotoxic effects produced by light, and synergism with cigarette smoke in the respiratory tract of hairless mice Carcinogenesis 24 2003 1525 1532
38. D.J. Howard, L.A. Briggs, and C.A. Pritsos Oxidative DNA damage in mouse heart, liver, and lung tissue due to acute side-stream tobacco smoke exposure Arch. Biochem. Biophys. 352 1998 293 297
39. J.M. Arif, C.G. Gairola, G.J. Kelloff, R.A. Lubet, and R.C.E. Gupta Inhibition of cigarette smoke-related DNA adducts in rat tissues by indole-3-carbinol Mutat. Res. 452 2000 11 18
40. R. Balansky, A. Izzotti, L. Scatolini, F. D'Agostini, and S. De Flora Induction by carcinogens and chemoprevention by N-acetylcysteine of adducts to mitochondrial DNA in rat organs Cancer Res. 56 1996 1642 1647
41. K. Rithidech, B.T. Chen, J.L. Mauderly Jr., E.B. Whorton, and A.L. Brooks Cytogenetic effects of cigarette smoke on pulmonary alveolar macrophages of the rat Environ. Mol. Mutagen. 14 1989 27 33
42. E. Mohtashamipur, K. Norpoth, and H. Straeter Clastogenic effect of passive smoking on bone marrow polychromatic erythrocytes of NMRI mice Toxicol. Lett. 35 1987 153 156
43. E. Mohtashamipur, T. Steinforth, and K. Norpoth Comparative bone marrow clastogenicity of cigarette sidestream, mainstream and recombined smoke condensates in mice Mutagenesis 3 1988 419 422
44. R.M. Balansky, P.M. Blagoeva, and Z.I. Mircheva Investigation of the mutagenic activity of tobacco smoke Mutat. Res. 188 1987 13 19
45. R.M. Balansky, P.M. Blagoeva, and Z.I. Mircheva The mutagenic and clastogenic activity of tobacco smoke Mutat. Res. 208 1988 237 241
46. R.M. Balansky, F. D'Agostini, and S. De Flora Induction, persistence and modulation of cytogenetic alterations in cells of smoke-exposed mice Carcinogenesis 20 1999 1491 1497
47. S. De Flora, R.M. Balansky, F. D'Agostini, A. Izzotti, A. Camoirano, C. Bennicelli, Z. Zhang, Y. Wang, R.A. Lubet, and M. You Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke Cancer Res. 63 2003 793 800
48. T. Karube, Y. Odagiri, K. Takemoto, and S. Watanabe Analyses of transplacentally induced sister chromatid exchanges and micronuclei in mouse fetal liver cells following maternal exposure to cigarette smoke Cancer Res. 49 1989 3550 3552
49. A. Izzotti, R.M. Balansky, C. Cartiglia, A. Camoirano, M. Longobardi, and S. De Flora Genomic and transcriptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke FASEB J. 17 2003 1127 1129
50. S.S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis 23 2002 907 922
51. S.S. Hecht Tobacco carcinogens, their biomarkers and tobacco-induced cancer Nat. Rev. Cancer 3 2003 733 744
52. S.S. Hecht Biochemistry, biology and carcinogenicity of tobacco specific N-nitrosamines Chem. Res. Toxicol. 11 1998 559 603
53. S.S. Hecht, S.G. Carmella, S.E. Murphy, S. Akerkar, K.D. Brunnemann, and D. Hoffmann A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke N. Engl. J. Med. 329 1993 1543 1546
54. W.D. Parsons, S.G. Carmella, S. Akerkar, L.E. Bonilla, and S.S. Hecht A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone in the urine of hospital workers exposed to environmental tobacco smoke Cancer Epidemiol. Biomarkers Prev. 7 1998 257 260
55. K.E. Anderson, S.G. Carmella, M. Ye, R.L. Bliss, C. Le, L. Murphy, and S.S. Hecht Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke J. Natl. Cancer Inst. 93 2001 378 381
56. S.G. Carmella, S. Han, A. Fristad, Y. Yang, and S.S. Hecht Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine Cancer Epidemiol. Biomarkers Prev. 12 2003 1257 1261
57. K.E. Anderson, J. Kliris, L. Murphy, S.G. Carmella, S. Han, C. Link, R.L. Bliss, S. Puumala, S.E. Murphy, and S.S. Hecht Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons Cancer Epidemiol. Biomarkers Prev. 12 2003 1544 1546
58. S.S. Hecht, M. Ye, S.G. Carmella, A. Fredrickson, J.L. Adgate, I.A. Greaves, T.R. Church, A.D. Ryan, S.J. Mongin, and K. Sexton Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children Cancer Epidemiol. Biomarkers Prev. 10 2001 1109 1116
59. H.T. Tsai, M.T. Wu, R. Hauser, E. Rodrigues, C.K. Ho, C.L. Liu, and D.C. Christiani Exposure to environmental tobacco smoke and urinary 1-hydroxypyrene levels in preschool children Kaohsiung J. Med. Sci. 19 2003 97 104
60. D.H. Phillips Smoking-related DNA and protein adducts in human tissues Carcinogenesis 23 2002 1979 2004
61. P. Georgiadis, J. Topinka, M. Stoikidou, S. Kaila, M. Gioka, K. Katsouyanni, R. Sram, H. Autrup, and S.A. Kyrtopoulos Biomarkers of genotoxicity of air pollution (the AULIS project): bulky DNA adducts in subjects with moderate to low exposures to airborne polycyclic aromatic hydrocarbons and their relationship to environmental tobacco smoke and other parameters Carcinogenesis 22 2001 1447 1457
62. D.J. Howard, R.B. Ota, L.A. Briggs, M. Hampton, and C.A. Pritsos Oxidative stress induced by environmental tobacco smoke in the workplace is mitigated by antioxidant supplementation Cancer Epidemiol. Biomarkers Prev. 7 1998 981 988
63. L. Yildiz, N. Kayaoglu, and H. Aksoy The changes of superoxide dismutase, catalase and glutathione peroxidase activities in erythrocytes of active and passive smokers Clin. Chem. Lab. Med. 40 2002 612 615
64. M. Dietrich, G. Block, N.L. Benowitz, J.D. Morrow, M. Hudes, P. Jacob III, E.P. Norkus, and L. Packer Vitamin C supplementation decreases oxidative stress biomarker f2-isoprostanes in plasma of nonsmokers exposed to environmental tobacco smoke Nutr. Cancer 45 2003 176 184
65. M. Maclure, R.B. Katz, M.S. Bryant, P.L. Skipper, and S.R. Tannenbaum Elevated blood levels of carcinogens in passive smokers Am. J. Public Health 79 1989 1381 1384
66. S.K. Hammond, J. Coghlin, P.H. Gann, M. Paul, K. Taghizadek, P.L. Skipper, and S.R. Tannenbaum Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers J. Natl. Cancer Inst. 85 1993 474 478
67. F.G. Crawford, J. Mayer, R.M. Santella, T.B. Cooper, R. Ottman, W.Y. Tsai, G. Simon-Cereijido, M. Wang, D. Tang, and F.P. Perera Biomarkers of environmental tobacco smoke in preschool children and their mothers J. Natl. Cancer Inst. 86 1994 1398 1402
68. D. Tang, D. Warburton, S.R. Tannenbaum, P. Skipper, R.M. Santella, G.S. Cereijido, F.G. Crawford, and F.P. Perera Molecular and genetic damage from environmental tobacco smoke in young children Cancer Epidemiol. Biomarkers Prev. 8 1999 427 431
69. G. Baier, G.H. Stopper, C. Kopp, U. Winkler, and I. Zwirner-Baier Respiratory diseases and genotoxicity in tobacco smoke exposed children Laryngo-Rhino-Otologie 81 2002 217 225 (In German)
70. O. Holz, R. Meißner, M. Einhaus, F. Koops, K. Warncke, G. Scherer, F. Adlkofer, E. Baumgartner, and H.W. Rüdiger Detection of DNA single-strand breaks in lymphocytes of smokers Int. Arch. Occup. Environ. Health 65 1993 83 88
71. T.H. Lam, C.Q. Zhu, and C.Q. Jiang Lymphocyte DNA damage in elevator manufacturing workers in Guangzhou China. Mutat. Res. 515 2002 147 157
72. G. Speit, T. Witton-Davies, W. Heepchantree, K. Trenz, and H. Hoffmann Investigations on the effect of cigarette smoking in the comet assay Mutat. Res. 542 2003 33 42
73. E. Yamasaki, and B.N. Ames Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine Proc. Natl. Acad. Sci. U.S.A. 74 1977 3555 3559
74. M. Sorsa, P. Einisto, K. Husgafvel-Pursiainen, H. Järventaus, H. Kivistö, Y. Peltonen, T. Tuomi, S. Valkonen, and O. Pelkonen Passive and active exposure to cigarette smoke in a smoking experiment J. Toxicol. Environ. Health 16 1985 523 534
75. K. Husgafvel-Pursiainen, M. Sorsa, K. Engstrom, and P. Einisto Passive smoking at work: biochemical and biological measures of exposure to environmental tobacco smoke Int. Arch. Occup. Environ. Health 59 1987 337 345
76. N.Y. Kado, S.J. Tesluk, S.K. Hammond, S.R.K. Woskie, S.J. Samuels, and M.B. Shenker Use of Salmonella micro pre-incubation procedure for studying personal exposure to mutagens in environmental tobacco smoke: pilot study of urine and airborne mutagenicity for passive smoking S.S. Sandhu D.M. DeMarine M.J. Mass M.M. Moore J.L. Mumford Short-Term Bioassays in the Analysis of Complex Environmental Mixtures V, Environ. Sci. Res. vol. 36 1988 Plenum Press New York pp. 375-390
77. H. Bartsch, N. Caporaso, M. Coda, F. Kadlubar, C. Malaveille, P. Skipper, G. Talaska, S.R. Tannenbaum, and P. Vineis Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers J. Natl. Cancer Inst. 82 1990 1826 1831
78. G. Scherer, D.J. Doolittle, T. Ruppert, I. Meger-Kossien, K. Riedel, A.R. Tricker, and F. Adlkofer Urinary mutagenicity and thioethers in nonsmokers: role of environmental tobacco smoke (ETS) and diet Mutat. Res. 368 1996 195 204
79. C.J. Smith, D.W. Bombick, B.A. Ryan, W.T. Morgan, and D.J. Doolittle Urinary mutagenicity in nonsmokers following exposure to fresh diluted sidestream cigarette smoke Mutat. Res. 470 2000 53 70
80. R. Vermeulen, H. Wegh, R.P. Bos, and H. Kromhout Weekly patterns in smoking habits and influence on urinary cotinine and mutagenicity levels: confounding effect of nonsmoking policies in the workplace Cancer Epidemiol. Biomarkers Prev. 9 2000 1205 1209
81. G. Scherer, C. von Maltzan, L. von Meyerinck, K. Westphal, and F. Adlkofer Biomonitoring after controlled exposure to environmental tobacco smoke (ETS) Exp. Pathol. 37 1989 158 163
82. G. Scherer, K. Westphal, A. Biber, I. Hoepfner, and F. Adlkofer Urinary mutagenicity after controlled exposure to environmental tobacco smoke (ETS) Toxicol. Lett. 35 1987 135 140
83. G. Scherer, C. Conze, L. von Meyerinck, M. Sorsa, and F. Adlkofer Importance of exposure to gaseous and particulate phase components of tobacco smoke in active and passive smokers Int. Arch. Occup. Environ. Health 62 1990 459 466
84. I.M. Sasson, D.T. Coleman, E.J. LaVoie, D. Hoffmann, and E.L. Wynder Mutagens in human urine: effects of cigarette smoking and diet Mutat. Res. 158 1985 149 157
85. C. Malaveille, P. Vineis, J. Esteve, H. Ohshima, G. Brun, A. Hautefeuille, P. Gallet, G. Ronco, B. Terracini, and H. Bartsch Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer Carcinogenesis 10 1989 577 586
86. S. Bonassi, M. Neri, C. Lando, M. Ceppi, Y. Lin, W.P. Chang, N. Holland, M. Kirsch-Volders, E. Zeiger, and M. Fenech Effect of smoking habit on the frequency of micronuclei in human lymphocytes: results from the human micronucleus project Mutat. Res. 543 2003 155 166
87. G.W. Collman, K. Lundgren, D. Shore, C.L. Thompson, and G.W. Lucier Effects of alpha-naphthoflavone on levels of sister chromatid exchanges in lymphocytes from active and passive cigarette smokers: dose-response relationships Cancer Res. 46 1986 6452 6455
88. K. Husgafvel-Pursiainen Sister-chromatid exchange and cell proliferation in cultured lymphocytes of passively and actively smoking restaurant personnel Mutat. Res. 190 1987 211 215
89. W.J. Gorgels, G. van Poppel, M.J. Jarvis, W. Stenhuis, and F.J. Kok Passive smoking and sister-chromatid exchanges in lymphocytes Mutat. Res. 279 1992 233 238
90. M. Sorsa, and K. Husgafvel-Pursiainen Assessment of passive and transplacental exposure to tobacco smoke IARC Sci. Publ. 89 1988 129 132
91. M. Sorsa, K. Husgafvel-Pursiainen, H. Järventaus, K. Koskimies, H. Salo, and H. Vainio Cytogenetic effects of tobacco smoke exposure among involuntary smokers Mutat. Res. 222 1989 111 116
92. R.J. Albertini, D. Anderson, G.R. Douglas, L. Hagmar, K. Hemminki, F. Merlo, A.T. Natarajan, H. Norppa, D.E. Shuker, R. Tice, M.D. Waters, and A. Aitio IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans, International Programme on Chemical Safety Mutat. Res. 463 2000 111 172
93. R.J. Albertini HPRT mutations in humans: biomarkers for mechanistic studies Mutat. Res. 489 2001 1 16
94. D.R. Robinson, K. Goodall, R.J. Albertini, J.P. O'Neill, B. Finette, M. Sala-Trepat, E. Moustacchi, A.D. Tates, D.M. Beare, M.H. Green, and J. Cole An analysis of in vivo hprt mutant frequency in circulating T-lymphocytes in the normal human population: a comparison of four datasets Mutat. Res. 313 1994 227 247
95. K.J. Burkhart-Schultz, C.L. Thompson, and I.M. Jones Spectrum of somatic mutation at the hypoxanthine phosphoribosyltransferase (hprt) gene of healthy people Carcinogenesis 17 1996 1871 1883
96. M.M. Ammenheuser, D.A. Hastings Jr., E.B. Whorton Jr., and J.B. Ward Frequencies of hprt mutant lymphocytes in smokers, non-smokers, and former smokers Environ. Mol. Mutagen. 30 1997 131 138
97. H. Vrieling, J.C. Thijssen, A.M. Rossi, F.J. van Dam, A.T. Natarajan, A.D. Tates, and A.A. van Zeeland Enhanced hprt mutant frequency but no significant difference in mutation spectrum between a smoking and a non-smoking human population Carcinogenesis 13 1992 1625 1631
98. J. Curry, L. Karnaoukhova, G.C. Guenette, and B.W. Glickman Influence of sex, smoking and age on human hprt mutation frequencies and spectra Genetics 152 1999 1065 1077
99. B.A. Finette, T. Poseno, P.M. Vacek, and R.J. Albertini The effects of maternal cigarette smoke exposure on somatic mutant frequencies at the hprt locus in healthy newborns Mutat. Res. 377 1997 115 123
100. B.A. Finette, J.P. O'Neill, P.M. Vacek, and R.J. Albertini Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke Nat. Med. 4 1998 1144 1151
101. W.L. Bigbee, R.D. Day, S.G. Grant, P. Keohavong, L. Xi, L. Zhang, and R.B. Ness Impact of maternal lifestyle factors on newborn HPRT mutant frequencies and molecular spectrum - initial results from the prenatal exposures and preeclampsia prevention (PEPP) study Mutat. Res. 431 1999 279 289
102. W.C. Hahn, and R.A. Weinberg Modelling the molecular circuitry of cancer Nat. Rev. 2 2002 331 341
103. D.P. Lane Cancer. p53, guardian of the genome Nature 358 1992 15 16
104. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris p53 Mutations in human cancers Science 253 1991 49 53
105. M.S. Greenblatt, W.P. Bennett, M. Hollstein, and C.C. Harris Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res. 54 1994 4855 4878
106. S.P. Hussain, and C.C. Harris Molecular epidemiology of human cancer - contribution of mutation spectra studies of tumor suppressor genes Cancer Res. 58 1998 4023 4037
107. P. Hainaut, and M. Hollstein p53 and human cancer: the first ten thousand mutations Adv. Cancer Res. 77 2000 81 137
108. T. Hernandez-Boussard, R. Montesano, and P. Hainaut Analysis of somatic mutations of the p53 gene in human cancers: a tool to generate hypotheses about the natural history of cancer IARC Sci. Publ. 146 1999 43 53
109. M. Sanchez-Cespedes, S.A. Ahrendt, S. Piantadosi, R. Rossell, M. Monzo, L. Wu, W.H. Westra, S.C. Yang, J. Jen, and D. Sidransky Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers Cancer Res. 61 2001 1309 1313
110. H. Suzuki, T. Takahashi, T. Kuroishi, M. Suyama, Y. Ariyoshi, and R. Ueda p53 Mutations in non-small cell lung cancer in Japan: association between mutations and smoking Cancer Res. 52 1992 734 736
111. K. Husgafvel-Pursiainen, and A. Kannio Cigarette smoking and p53 mutations in lung cancer and bladder cancer Environ. Health Perspect. 104 1996 553 556
112. K. Husgafvel-Pursiainen, P. Boffetta, A. Kannio, F. Nyberg, G. Pershagen, A. Mukeria, V. Constantinescu, C. Fortes, and S. Benhamou p53 Mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer Cancer Res. 60 2000 2906 2911
113. S.A. Ahrendt, J.T. Chow, S.C. Yang, L. Wu, M.J. Zhang, J. Jen, and D. Sidransky Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer Cancer Res. 60 2000 3155 3159
114. K.H. Vähäkangas, W.P. Bennett, K. Castren, J.A. Welsh, M.A. Khan, B. Blomeke, M.C. Alavanja, and C.C. Harris p53 and K-ras mutations in lung cancers from former and never-smoking women Cancer Res. 61 2001 4350 4356
115. Y. Takeshima, T. Seyama, W.P. Bennett, M. Akiyama, S. Tokuoka, K. Inai, K. Mabuchi, C.E. Land, and C.C. Harris p53 Mutations in lung cancers from non-smoking atomic-bomb survivors Lancet 342 1993 1520 1521 (published erratum, Lancet 343 (1994) 1302)
116. X. Wang, D.C. Christiani, J.K. Wiencke, M. Fischbein, X. Xu, T.J. Cheng, E. Mark, J.C. Wain, and K.T. Kelsey Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure Cancer Epidemiol. Biomarkers Prev. 4 1995 543 548
117. K. Kondo, H. Tsuzuki, M. Sasa, M. Sumitomo, T. Uyama, and Y. Monden A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients J. Surg. Oncol. 61 1996 20 26
118. K. Husgafvel-Pursiainen, A. Karjalainen, A. Kannio, S. Anttila, T. Partanen, A. Ojajärvi, and H. Vainio Lung cancer and past occupational exposure to asbestos, Role of p53 and K-ras mutations Am. J. Respir. Cell Mol. Biol. 20 1999 667 674
119. P. Hainaut, and G.P. Pfeifer Patterns of p53 G->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis 22 2001 367 374
120. M.F. Denissenko, A. Pao, G.P. Pfeifer, and M. Tang Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers Oncogene 16 1998 1241 1247
121. G.P. Pfeifer, and P. Hainaut On the origin of G->T transversions in lung cancer Mutat. Res. 526 2003 39 43
122. M.F. Denissenko, A. Pao, M. Tang, and G.P. Pfeifer Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53 Science 274 1996 430 432
123. L.E. Smith, M.F. Denissenko, W.P. Bennett, H. Li, S. Amin, M. Tang, and G.P. Pfeifer Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons J. Natl. Cancer Inst. 92 2000 803 811 (see comments)
124. M.F. Denissenko, J.X. Chen, M.S. Tang, and G.P. Pfeifer Cytosine methylation determines hot spots of DNA damage in the human P53 gene Proc. Natl. Acad. Sci. U.S.A. 94 1997 3893 3898
125. J.X. Chen, Y. Zheng, M. West, and M.S. Tang Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots Cancer Res. 58 1998 2070 2075
126. J.H. Yoon, L.E. Smith, Z. Feng, M. Tang, C.S. Lee, and G.P. Pfeifer Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers Cancer Res. 61 2001 7110 7117
127. S.N. Rodin, A.S. Rodin, A. Juhasz, and G.P. Holmquist Cancerous hyper-mutagenesis in p53 genes in possibly associated with transcriptional bypass of DNA lesions Mutat. Res. 510 2002 153 168
128. S.N. Rodin, and A.S. Rodin On the excess of G->T transversions in the p53 gene in lung cancer cell lines reply to Pfeifer and Hainaut Mutat. Res. 545 2004 141 144
129. H. Rubin Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis Oncogene 21 2002 7392 7411
130. C. Huang, T. Taki, M. Adachi, T. Konishi, M. Higashiyama, and M. Miyake Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer Oncogene 16 1998 2469 2477
131. A. Marchetti, S. Pellegrini, G. Sozzi, G. Bertacca, P. Gaeta, F. Buttitta, V. Carnicelli, P. Griseri, A. Chella, C.A. Angeletti, M. Pierotti, and G. Bevilacqua Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus Br. J. Cancer 78 1998 73 78
132. Y. Takagi, H. Osada, T. Kuroishi, T. Mitsudomi, M. Kondo, T. Niimi, S. Saji, A.F. Gazdar, T. Takahashi, and J.D. Minna p53 Mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking Br. J. Cancer 77 1998 1568 1572
133. R. Gealy, L. Zhang, J.M. Siegfried, J.D. Luketich, and P. Keohavong Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women Cancer Epidemiol. Biomarkers Prev. 8 1999 297 302
134. D.M. DeMarini, S. Landi, D. Tian, N.M. Hanley, X. Li, F. Hu, B.C. Roop, M.J. Mass, P. Keohavong, W. Gao, M. Olivier, P. Hainaut, and J.L. Mumford Lung tumor KRAS and TP53 mutations in nonsmokers reflect exposure to PAH-rich coal combustion emissions Cancer Res. 61 2001 6679 6681
135. C.A. Granville, N.M. Hanley, J.L. Mumford, and D.M. DeMarini Mutation spectra of smoky coal combustion emissions in Salmonella reflect the TP53 and KRAS mutations in lung tumors from smoky coal-exposed individuals Mutat. Res. 525 2003 77 83
136. S. Rodenhuis, R.J. Slebos, A.J. Boot, S.G. Evers, W.J. Mooi, S.S. Wagenaar, P.C. van Bodegom, and J.L. Bos Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung Cancer Res. 48 1988 5738 5741
137. R.J. Slebos, R.H. Hruban, O. Dalesio, W.J. Mooi, G.J. Offerhaus, and S. Rodenhuis Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung J. Natl. Cancer Inst. 83 1991 1024 1027
138. S. Rodenhuis, and R.J. Slebos Clinical significance of ras oncogene activation in human lung cancer Cancer Res. 52 1992 2665 2669
139. K. Husgafvel-Pursiainen, P. Hackman, M. Ridanpaa, S. Anttila, A. Karjalainen, T. Partanen, O. Taikina-Aho, L. Heikkila, and H. Vainio K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos Int. J. Cancer 53 1993 250 256
140. W.H. Westra, G.J. Offerhaus, S.N. Goodman, R.J. Slebos, M. Polak, I.O. Baas, S. Rodenhuis, and R.H. Hruban Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking Am. J. Surg. Pathol. 17 1993 213 220
141. P. Keohavong, Q. Lan, W.-M. Gao, D.M. DeMarini, M.J. Mass, X.-M. Li, B.C. Roop, J. Weissfeld, D. Tian, and J.L. Mumford K-ras mutations in lung carcinomas from nonsmoking women exposed to unvented coal smoke in China Lung Cancer 41 2003 21 27
142. D.W. Nebert, and D.W. Russell Clinical importance of the cytochromes P450 Lancet 360 2002 1155 1162
143. F.P. Perera Environment and cancer: who are susceptible? Science 278 1997 1068 1073
144. A. d'Errico, N. Malats, P. Vineis, and P. Boffetta Review of studies of selected metabolic polymorphisms and cancer IARC Sci. Publ. 148 1999 323 393 (Chapter 23)
145. H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic polymorphisms of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers Cancer Epidemiol. Biomarkers Prev. 9 2000 3 28
146. S. Benhamou, W.L. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewitz, J. Brockmöller, M.L. Clapper, A. Daly, V. Dolzan, J. Ford, L. Gaspari, A. Haugen, A. Hirvonen, K. Husgafvel-Pursiainen, M. Ingelman-Sundberg, I. Kalina, M. Kihara, P. Kremers, L. Le Marchand, S.J. London, V. Nazar-Steward, M. Onon-Kihara, A. Rannug, M. Romkes, D. Ryberg, J. Seidegard, P. Shields, R.C. Strange, I. Stücker, J. To-Figueras, P. Brennan, and E. Taioli Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphism and smoking on lung cancer risk Carcinogenesis 23 2002 1343 1350
147. M. Berwick, and P. Vineis Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review J. Natl. Cancer Inst. 92 2000 874 897
148. P. Vineis, H. Bartsch, N. Caporaso, A.M. Harrington, F.F. Kadlubar, M.T. Landi, C. Malaveille, P.G. Shields, P. Skipper, G. Talaska, and S.R. Tannenbaum Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens Nature 369 1994 154 156
149. W.P. Bennett, M.C. Alavanja, B. Blomeke, K.H. Vähäkangas, K. Castren, J.A. Welsh, E.D. Bowman, M.A. Khan, D.B. Flieder, and C.C. Harris Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women J. Natl. Cancer Inst. 91 1999 2009 2014 (see comments)
150. F. Nyberg, S.M. Hou, K. Hemminki, B. Lambert, and G. Pershagen Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls Cancer Epidemiol. Biomarkers Prev. 7 1998 875 883
151. N. Malats, A.M. Camus-Radon, F. Nyberg, W. Ahrens, V. Constantinescu, A. Mukeria, S. Benhamou, H. Batura-Gabryel, I. Bruske-Hohlfeld, L. Simonato, A. Menezes, S. Lea, M. Lang, and P. Boffetta Lung cancer risk in nonsmokers and GSTM1 and GSTT1 genetic polymorphism Cancer Epidemiol. Biomarkers Prev. 9 2000 827 833
152. R.J. Hung, P. Boffetta, J. Brockmöller, D. Butkiewicz, I. Cascorbi, M.L. Clapper, S. Garte, A. Haugen, A. Hirvonen, S. Anttila, I. Kalina, L. Le
153. C. Kiyohara, K. Wakai, H. Mikami, K. Sido, M. Ando, and Y. Ohno Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of environmental tobacco smoke and lung cancer: a case-control study in Japanese nonsmoking women Int. J. Cancer 107 2003 139 144
154. E. Taioli, L. Gaspari, S. Benhamou, P. Boffetta, J. Brockmoller, D. Butkiewicz, I. Cascorbi, M.L. Clapper, V. Dolzan, A. Haugen, A. Hirvonen, K. Husgafvel-Pursiainen, I. Kalina, P. Kremers, L. Le Marchand, S. London, A. Rannug, M. Romkes, B. Schoket, J. Seidegard, R.C. Strange, I. Stucker, J. To-Figueras, and S. Garte Polymorphisms in CYP1A1, GSTM1, GSTT1 and lung cancer below the age of 45 years Int. J. Epidemiol. 32 2003 60 63
155. L. Le Marchand, C. Guo, S. Benhamou, C. Bouchardy, I. Cascorbi, M.L. Clapper, S. Garte, A. Haugen, M. Ingelman-Sundberg, M. Kihara, A. Rannug, D. Ryberg, I. Stücker, H. Sugimura, and E. Taioli Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States) Cancer Causes Control 14 2003 339 346
156. D.P. Miller, I. De Vivo, D. Neuberg, J.C. Wain, T.J. Lynch, L. Su, and D.C. Christiani Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism Int. J. Cancer 104 2003 758 763
157. 6-alkylguanine DNA alkyltranferase gene and lung cancer risk in non-smokers exposed to second-hand smoke Cancer Epidemiol. Biomarkers Prev. 13 2004 320 323
158. B. Zhu, C. Heeschen, R.E. Sievers, J.S. Karliner, W.W. Parmley, S.A. Glantz, and J.P. Cooke Second hand smoke stimulates tumor angiogenesis and growth Cancer Cell 4 2003 191 196
159. C. Heeschen, J.J. Jang, M. Weis, A. Pathak, S. Kaji, R.S. Hu, P.S. Tsao, F.L. Johnson, and J.P. Cooke Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis Nat. Med. 7 2001 833 839
160. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat. Rev. Genet. 3 2002 415 428
161. J.G. Herman, and S.B. Baylin Gene silencing in cancer in association with promoter hypermethylation N. Engl. J. Med. 349 2003 2042 2054
162. D.H. Kim, H.H. Nelson, J.K. Wiencke, S. Zheng, D.C. Christiani, J.C. Wain, E.J. Mark, and K.T. Kesey p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer Cancer Res. 61 2001 3419 3424
163. S. Toyooka, R. Maruyama, K.O. Toyooka, D. McLerran, Z. Feng, Y. Fukuyama, A.K. Virmani, S. Zochbauer-Muller, K. Tsukuda, K. Sugio, N. Shimizu, K. Shimizu, H. Lee, C.-Y. Chen, K.M. Fong, M. Gilcrease, J.A. Roth, J.D. Minna, and A.F. Gazdar Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer Int. J. Cancer 103 2003 153 160
164. S. Jarmalaite, A. Kannio, S. Anttila, J.R. Lazutka, and K. Husgafvel-Pursiainen Aberrant p16 promoter methylation in smokers and former smokers with non-small cell lung cancer Int. J. Cancer 106 2003 913 918
165. S.A. Belinsky, K.J. Nikula, W.A. Palmisano, R. Michels, G. Saccomanno, E. Gabrielson, S.B. Baylin, and J.G. Herman Aberrant methylation of p16 (INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis Proc. Natl. Acad. Sci. U.S.A. 95 1998 11891 11896
166. S. Zochbauer-Muller, K.M. Fong, A.K. Virmani, J. Geradts, A.F. Gazdar, and J.D. Minna Aberrant promoter methylation of multiple genes in non-small cell lung cancers Cancer Res. 61 2001 249 255
167. S.A. Belinsky, W.A. Palmisano, F.D. Gilliland, L.A. Crooks, K.K. Divine, S.A. Winters, M.J. Grimes, H.J. Harms, C.S. Tellez, T.M. Smith, P.P. Moots, J.F. Lechner, C.A. Stidley, and R.E. Crowell Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers Cancer Res. 62 2002 2370 2377
168. M. Esteller, P.G. Corn, J.M. Urena, E. Gabrielson, S.B. Baylin, and J.G. Herman Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia Cancer Res. 58 1998 4515 4518
169. S. Anttila, J. Hakkola, P. Tuominen, E. Elovaara, K. Husgafvel- Pursiainen, A. Karjalainen, A. Hirvonen, and T. Nurminen Methylation of cytochrome P4501A1 promoter in the lung is associated with tobacco smoking Cancer Res. 63 2003 8623 8628